Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

439. Cheung AN, Chan AC, Chung LP, Chan
TM, Cheng IK, Chan KW (1998). Post-transplantation
lymphoproliferative disorder of
donor origin in a sex-mismatched renal
allograft as proven by chromosome in situ
hybridization. Mod Pathol 11: 99-102.
440. Cheville JC (1998). Urothelial carcinoma
of the prostate: an immunohistochemical
comparison with high grade prostatic
adenocarcinoma and review of the literature.
J Urol Pathol 9: 141-154.
441. Cheville JC, Blute ML, Zincke H, Lohse
CM, Weaver AL (2001). Stage pT1 conventional
(clear cell) renal cell carcinoma:
pathological features associated with cancer
specific survival. J Urol 166: 453-456.
442. Cheville JC, Dundore PA, Bostwick
DG, Lieber MM, Batts KP, Sebo TJ, Farrow
GM (1998). Transitional cell carcinoma of
the prostate: clinicopathologic study of 50
cases. Cancer 82: 703-707.
443. Cheville JC, Dundore PA, Nascimento
AG, Meneses M, Kleer E, Farrow GM,
Bostwick DG (1995). Leiomyosarcoma of
the prostate. Report of 23 cases. Cancer
76: 1422-1427.
444. Cheville JC, Rao S, Iczkowski KA,
Lohse CM, Pankratz VS (2000). Cytokeratin
expression in seminoma of the human
testis. Am J Clin Pathol 113: 583-588.
445. Cheville JC, Sebo TJ, Lager DJ,
Bostwick DG, Farrow GM (1998). Leydig
cell tumor of the testis: a clinicopathologic,
DNA content, and MIB-1 comparison of
nonmetastasizing and metastasizing
tumors. Am J Surg Pathol 22: 1361-1367.
446. Cheville JC, Tindall D, Boelter C,
Jenkins R, Lohse CM, Pankratz VS, Sebo
TJ, Davis B, Blute ML (2002). Metastatic
prostate carcinoma to bone: clinical and
pathologic features associated with cancer-specific
survival. Cancer 95: 1028-
1036.
447. Cheville JC, Wu K, Sebo TJ, Cheng L,
Riehle D, Lohse CM, Shane V (2000).
Inverted urothelial papilloma: is ploidy,
MIB-1 proliferative activity, or p53 protein
accumulation predictive of urothelial carcinoma?
Cancer 88: 632-636.
448. Chin KC, Perry GJ, Dowling JP,
Thomson NM (1999). Primary T-cell-rich B-
cell lymphoma in the kidney presenting
with acute renal failure and a second
malignancy. Pathology 31: 325-327.
449. Chin NW, Marinescu AM, Fani K
(1992). Composite adenocarcinoma and
carcinoid tumor of urinary bladder.
Urology 40: 249-252.
450. Chin W, Fay R, Ortega P (1986).
Malignant fibrous histiocytoma of
prostate. Urology 27: 363-365.
451. Chiou RK, Limas C, Lange PH (1985).
Hemangiosarcoma of the seminal vesicle:
case report and literature review. J Urol
134: 371-373.
452. Chiu TY, Huang HS, Lai MK, Chen J,
Hsieh TS, Chueh SC (1998). Penile cancer
in Taiwan—20 years’ experience at
National Taiwan University Hospital. J
Formos Med Assoc 97: 673-678.
453. Choi H, Almagro UA, McManus JT,
Norback DH, Jacobs SC (1983). Renal
oncocytoma. A clinicopathologic study.
Cancer 51: 1887-1896.
454. Choi H, Lamb S, Pintar K, Jacobs SC
(1984). Primary signet-ring cell carcinoma
of the urinary bladder. Cancer 53: 1985-
1990.
455. Choi YL, Song SY (2001). Cytologic clue
of so-called nodular histiocytic hyperplasia
of the pleura. Diagn Cytopathol 24: 256-
259.
456. Chor PJ, Gaum LD, Young RH (1993).
Clear cell adenocarcinoma of the urinary
bladder: report of a case of probable mullerian
origin. Mod Pathol 6: 225-228.
457. Chow NH, Tzai TS, Lin SN, Chan SH,
Tang MJ (1993). Reappraisal of the biological
role of epidermal growth factor receptor
in transitional cell carcinoma. Eur Urol 24:
140-143.
458. Chow WH, Gridley G, Fraumeni JFJr,
Jarvholm B (2000). Obesity, hypertension,
and the risk of kidney cancer in men. N Engl
J Med 343: 1305-1311.
459. Chowdhury PR, Tsuda N, Anami M,
Hayashi T, Iseki M, Kishikawa M, Matsuya
F, Kanetake H, Saito Y (1996). A histopathologic
and immunohistochemical study of
small nodules of renal angiomyolipoma: a
comparison of small nodules with angiomyolipoma.
Mod Pathol 9: 1081-1088.
460. Christensen TE, Ladefoged J (1979).
[Uroepithelial tumors in patients with contracted
kidneys and massive abuse of analgesics
(phenacetin)]. Ugeskr Laeger 141:
3522-3524.
461. Christensen WN, Partin AW, Walsh PC,
Epstein JI (1990). Pathologic findings in clinical
stage A2 prostate cancer. Relation of
tumor volume, grade, and location to pathologic
stage. Cancer 65: 1021-1027.
462. Christensen WN, Steinberg G, Walsh
PC, Epstein JI (1991). Prostatic duct adenocarcinoma.
Findings at radical prostatectomy.
Cancer 67: 2118-2124.
463. Christiano AP, Yang X, Gerber GS
(1999). Malignant transformation of renal
angiomyolipoma. J Urol 161: 1900-1901.
464. Chu PG, Weiss LM (2001). Cytokeratin
14 immunoreactivity distinguishes oncocytic
tumour from its renal mimics: an immunohistochemical
study of 63 cases.
Histopathology 39: 455-462.
465. Chuang GS, Martinez-Mir A, Horev L,
Glaser B, Geyer A, Landau M, Waldman A,
Gordon D, Spelman LJ, Hatzibougias I,
Engler DE, Cserhalmi-Friedman PB, Green
JS, Garcia Muret MP, Prieto Cid M, Brenner
S, Sprecher E, Christiano AM, Zlotogorski A
(2003). Germline fumarate hydratase mutations
and evidence for a founder mutation
underlying multiple cutaneous and uterine
leiomyomata. The American Journal of
Human Genetics 73 (Supplement): 577.
466. Cibas ES, Goss GA, Kulke MH, Demetri
GD, Fletcher CD (2001). Malignant epithelioid
angiomyolipoma (‘sarcoma ex
angiomyolipoma’) of the kidney: a case
report and review of the literature. Am J
Surg Pathol 25: 121-126.
467. Cina SJ, Epstein JI (1997).
Adenocarcinoma of the prostate with
atrophic features. Am J Surg Pathol 21: 289-
295.
468. Cina SJ, Epstein JI, Endrizzi JM,
Harmon WJ, Seay TM, Schoenberg MP
(2001). Correlation of cystoscopic impression
with histologic diagnosis of biopsy
specimens of the bladder. Hum Pathol 32:
630-637.
469. Cina SJ, Lancaster-Weiss KJ, Lecksell
K, Epstein JI (2001). Correlation of Ki-67 and
p53 with the new World Health
Organization/International Society of
Urological Pathology Classification System
for Urothelial Neoplasia. Arch Pathol Lab
Med 125: 646-651.
470. Civantos F, Marcial MA, Banks ER, Ho
CK, Speights VO, Drew PA, Murphy WM,
Soloway MS (1995). Pathology of androgen
deprivation therapy in prostate carcinoma.
A comparative study of 173 patients. Cancer
75: 1634-1641.
471. Clark J, Lu YJ, Sidhar SK, Parker C, Gill
S, Smedley D, Hamoudi R, Linehan WM,
Shipley J, Cooper CS (1997). Fusion of
splicing factor genes PSF and NonO
(p54nrb) to the TFE3 gene in papillary renal
cell carcinoma. Oncogene 15: 2233-2239.
472. Clasen S, Schulz WA, Gerharz CD,
Grimm MO, Christoph F, Schmitz-Drager
BJ (1998). Frequent and heterogeneous
expression of cyclin-dependent kinase
inhibitor WAF1/p21 protein and mRNA in
urothelial carcinoma. Br J Cancer 77: 515-
521.
473. Clemente Ramos LM, Garcia Gonzalez
R, Burgos Revilla FJ, Maganto Pavon E,
Fernandez Canadas S, Blazquez Gomez J,
Carrera Puerta C, Escudero Barrilero A
(1998). [Hybrid tumor of the penis: is this
denomination correct?]. Arch Esp Urol 51:
821-823.
474. Clifford SC, Prowse AH, Affara NA,
Buys CH, Maher ER (1998). Inactivation of
the von Hippel-Lindau (VHL) tumour suppressor
gene and allelic losses at chromosome
arm 3p in primary renal cell carcinoma:
evidence for a VHL-independent
pathway in clear cell renal tumourigenesis.
Genes Chromosomes Cancer 22: 200-
209.
475. Cochand-Priollet B, Molinie V,
Bougaran J, Bouvier R, Dauge-Geffroy MC,
Deslignieres S, Fournet JC, Gros P,
Lesourd A, Saint-Andre JP, Toublanc M,
Vieillefond A, Wassef M, Fontaine A,
Groleau L (1997). Renal chromophobe cell
carcinoma and oncocytoma. A comparative
morphologic, histochemical, and
immunohistochemical study of 124 cases.
Arch Pathol Lab Med 121: 1081-1086.
476. Cohen AJ, Li FP, Berg S, Marchetto
DJ, Tsai S, Jacobs SC, Brown RS (1979).
Hereditary renal-cell carcinoma associated
with a chromosomal translocation. N
Engl J Med 301: 592-595.
477. Cohen J, Diamond J (1953). Leontiasis
ossea, slipped epiphyses and granulosa
cell tumor of the testis with renal disease:
report of a case with autopsy findings.
Arch Pathol 56: 488-500.
478. Cohen RJ, Glezerson G, Haffejee Z
(1991). Neuro-endocrine cells—a new
prognostic parameter in prostate cancer.
Br J Urol 68: 258-262.
479. Cohen RJ, McNeal JE, Baillie T (2000).
Patterns of differentiation and proliferation
in intraductal carcinoma of the prostate:
significance for cancer progression.
Prostate 43: 11-19.
480. Colby TV (1980). Carcinoid tumor of the
bladder. A case report. Arch Pathol Lab
Med 104: 199-200.
481. Coleman MP, Esteve J, Damiecki P,
Arslan A, Renard H (1993). Trends in cancer
incidence and mortality. IARC Sci Publ
121 1-806.
482. Collins DH, Symington T (1964). Sertolicell
tumor. Br J Urol 36: 52-61.
483. Collins GN, Lee RJ, McKelvie GB,
Rogers AC, Hehir M (1993). Relationship
between prostate specific antigen,
prostate volume and age in the benign
prostate. Br J Urol 71: 445-450.
484. Comiter CV, Kibel AS, Richie JP, Nucci
MR, Renshaw AA (1998). Prognostic features
of teratomas with malignant transformation:
a clinicopathological study of 21
cases. J Urol 159: 859-863.
485. Congregado Ruiz B, Campoy Martinez
P, Luque Barona R, Garcia Ramos JB,
Perez Perez M, Soltero Gonzalez A (2001).
[Fibroepithelial polyp of the urethra in a
young woman]. Actas Urol Esp 25: 377-379.
486. Contractor H, Zariwala M, Bugert P,
Zeisler J, Kovacs G (1997). Mutation of the
p53 tumour suppressor gene occurs preferentially
in the chromophobe type of
renal cell tumour. J Pathol 181: 136-139.
487. Cook JA, Oliver K, Mueller RF,
Sampson J (1996). A cross sectional study
of renal involvement in tuberous sclerosis.
J Med Genet 33: 480-484.
488. Cook PJ, Doll R, Fellingham SA (1969).
A mathematical model for the age distribution
of cancer in man. Int J Cancer 4:
93-112.
489. Coombs LM, Pigott DA, Sweeney E,
Proctor AJ, Eydmann ME, Parkinson C,
Knowles MA (1991). Amplification and
over-expression of c-erbB-2 in transitional
cell carcinoma of the urinary bladder.
Br J Cancer 63: 601-608.
490. Coovadia YM (1978). Primary testicular
tumours among White, Black and
Indian patients. S Afr Med J 54: 351-352.
491. Copeland JN, Amin MB, Humphrey
PA, Tamboli P, Ro JY, Gal AA (2002). The
morphologic spectrum of metastatic prostatic
adenocarcinoma to the lung: special
emphasis on histologic features overlapping
with other pulmonary neoplasms.
Am J Clin Pathol 117: 552-557.
492. Coppes MJ, Arnold M, Beckwith JB,
Ritchey ML, D’Angio GJ, Green DM,
Breslow NE (1999). Factors affecting the
risk of contralateral Wilms tumor development:
a report from the National Wilms
Tumor Study Group. Cancer 85: 1616-1625.
493. Coppes MJ, Haber DA, Grundy PE
(1994). Genetic events in the development
of Wilms’ tumor. N Engl J Med 331: 586-
590.
494. Cordon-Cardo C, Cote RJ, Sauter G
(2000). Genetic and molecular markers of
urothelial premalignancy and malignancy.
Scand J Urol Nephrol Suppl 205: 82-
93.
495. Cordon-Cardo C, Dalbagni G, Saez
GT, Oliva MR, Zhang ZF, Rosai J, Reuter
VE, Pellicer A (1994). p53 mutations in
human bladder cancer: genotypic versus
phenotypic patterns. Int J Cancer 56: 347-
353.
496. Cordon-Cardo C, Koff A, Drobnjak M,
Capodieci P, Osman I, Millard SS, Gaudin
PB, Fazzari M, Zhang ZF, Massague J,
Scher HI (1998). Distinct altered patterns
of p27KIP1 gene expression in benign
prostatic hyperplasia and prostatic carcinoma.
J Natl Cancer Inst 90: 1284-1291.
497. Cordon-Cardo C, Reuter VE (1997).
Alterations of tumor suppressor genes in
bladder cancer. Semin Diagn Pathol 14:
123-132.
498. Cordon-Cardo C, Wartinger D,
Petrylak D, Dalbagni G, Fair WR, Fuks Z,
Reuter VE (1992). Altered expression of
the retinoblastoma gene product: prognostic
indicator in bladder cancer. J Natl
Cancer Inst 84: 1251-1256.
499. Corica FA, Husmann DA, Churchill
BM, Young RH, Pacelli A, Lopez-Beltran
A, Bostwick DG (1997). Intestinal metaplasia
is not a strong risk factor for bladder
cancer: study of 53 cases with long-term
follow-up. Urology 50: 427-431.
500. Corless CL, Kibel AS, Iliopoulos O,
Kaelin WGJr (1997). Immunostaining of
the von Hippel-Lindau gene product in
normal and neoplastic human tissues.
Hum Pathol 28: 459-464.
501. Cortes D, Visfeldt J, Moller H, Thorup
J (1999). Testicular neoplasia in cryptorchid
boys at primary surgery: case
series. BMJ 319: 888-889.
References 313